Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News out!
UV Flu Technology Commences National TV Brand Awareness Campaign
BARNSTABLE, Mass., March 27, 2013 /PRNewswire via COMTEX/ -- UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company") announced today that the Company has retained Stardust Broadcasting to run approximately 500 sixty-second television spots on a variety of national stations, with the intent of building the brand, and educating the consumer about the dangers of indoor air pollution.
"These commercials are the beginning of a long-term program to drive sales, while informing viewers how they can protect their loved ones from the spread of airborne diseases, allergens, and virtually all other forms of indoor air pollution. According to Stardust, the ads will start running later this week on stations such as CNN, ESPN, Fox News, Fox Sports and the Discovery Channel," said Jack Lennon, President of UV Flu.
"We are very excited about this first phase of our ramp-up. We have spent the last 18 months testing and evaluating the many applications for our products, and now we can focus on ramping up production to meet the demand we foresee from addressing the needs of each of these markets," said Mr. Lennon
"It turns out that there are major subsets to the overall residential market that are huge, but need user specific marketing approaches that we are now rolling out. If you have allergies or asthma, are pregnant or have small children, are undergoing any medical treatments, own a pet bird, dog, or cat, are a smoker or the spouse of a smoker, if your home suffers from mold and mildew, if you snore or have sleep problems, or are the spouse of one, or if you work in the field of medicine, education, travel or retail, your health, and the health of your family could be at risk," said Mr. Lennon.
Further details regarding the Company's business, acquisitions, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, visit: www.uvflutech.com, and click on the 5 minute video describing the ViraTech UV-400.
About UV Flu Technologies, Inc. (OTCQB: UVFT)UV Flu Technologies is an innovative developer; manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector ($7 billion in 2011). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: www.uvflutech.com.
Notice Regarding Forward-Looking StatementsThis news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Investor Information: Toll-Free: 1-877-358-5545 (FLU-KILL) Web: www.uvflutech.com
Retail or Internet Inquires: Please call our Corporate Office at: 508-362-5455
SOURCE UV Flu Technologies, Inc.
http://rt.prnewswire.com/rt.gif?NewsItemId=NE83961&Transmission_Id=201303270830PR_NEWS_USPR_____NE83961&DateId=20130327
www.prnewswire.com
Copyright (C) 2013 PR Newswire. All rights reserved
-0-
KEYWORD: Massachusetts
INDUSTRY KEYWORD: OTC
HEA
ADV
HHP
HOU
Scull & Cross Bones? Why?
News out!
UV-based Air Purification, A New Way To Fight The Flu
CENTERVILLE, Mass., Feb 12, 2013 /PRNewswire via COMTEX/ -- UV Flu Technologies, Inc. (OTCQB: UVFT) (the "Company") announced today there is good news for those living in the 47 states that are reporting widespread flu activity. UVFLU has developed the only pure UV based, FDA-cleared, class 2 medical device for fighting airborne infection and is now offering it to consumers. The Company has spent millions of dollars developing this unit and in the past has sold the unit mostly to hospitals and other medical facilities.
The Company has just launched a Groupon with special pricing during the current flu outbreak, which can be taken advantage of by visiting http://www.groupon.com/deals/gg-air-purification-system We felt Groupon was the perfect Company to help with the consumer launch given their huge marketing and logistics capability.
The Viratech UV-400 is an FDA Cleared Class II Medical Device for killing over 99% of airborne bacteria, along with a host of other contaminants, including odors, smoke, and toxic chemicals, with every pass, in rooms up to 800 sq. feet. The device is unique in that it uses germicidal ultra violet light to actually kill organic contaminants, versus typical air purifiers which only "trap" contaminants.
This year's flu season is now in full swing and hitting earlier and stronger than anytime in the past decade, according to the Centers for Disease Control and Prevention (CDC)." Reports of Influenza-like-illness (ILI), are nearing what have been peak levels during moderately severe seasons, according to Dr. Joe Bresee, Chief of Epidemiology and Prevention Branch in CDC's Influenza Division. "While influenza vaccination offers the best protection we have against influenza, it's still possible that some people may become ill despite being vaccinated."
People who are most susceptible to flu complications include young children, people sixty-five and older, pregnant women and those with underlying medical conditions. While everyone should take extra precautions this time of year, these groups are urged to take simple, additional steps to remove or kill contaminated air before they breathe it in. Flu viruses can be transmitted from coughs and sneezes up to 6 feet away, and the average person breathes 3600 gallons of air per day, so indoor air quality is essential.
Germicidal UV light has been found to be one of the most effective methods of killing both airborne and surface contamination, caused by bacteria and viruses. Hospitals routinely use ultraviolet light to kill bacteria and viruses on surfaces, and in the air. UV Flu Technology has developed residential, air purifiers that utilize this hospital-grade method.
"This serious outbreak may only be the beginning of a host of airborne diseases becoming major headlines over the next several years," said Jack Lennon, President of UV Flu Technologies. "Flu, Whooping Cough, TB, MRSA, Staph, and a host of other airborne transmitted diseases are coming back, many of which have grown resistant to treatments using antibiotics. The extensive use of antibiotics over the last few decades have contributed to lower immune response systems in many Americans. Children, seniors, and anyone undergoing transplants, or other medical treatments, which lower the immune response, are at serious risk of getting potentially fatal bacterial infections. The strain of Tuberculosis now appearing in India and Eastern Europe is now infecting millions of people, with fatality rates sometimes exceeding 50%," said Mr. Lennon. "Although, on average, 36,000 people die from flu-like symptoms annually in this country, many times more die from bacterial infections, and up to 500,000 may die from diseases related to cardiopulmonary diseases related to indoor air pollution."
Anybody interested in learning more about how UVFLU's technology can call the company TOLL FREE at (877)-FLU-KILL - (877) 358-5455.
News out!
CENTERVILLE, Mass., Dec. 12, 2012 /PRNewswire via COMTEX/ -- UV Flu Technologies, Inc. (OTCBB: UVFT)(the "Company") is pleased to announce plans for a 2013 rollout for its patented FDA Cleared Viratech 400 and RX Air units. To date the Company has spent over a decade and several million dollars developing the best air purification technology in the world. The device offers the most cost-effective system for treating all forms of indoor air pollution on the market today, with a cost of ownership which typically runs about 25 cents per day. In the next few months the Company will be executing on five main areas:
Top Tier Retailers
Internet and Specialty Retailers
Medical Sales
Enforcing & Licensing our Patented Technology
International Expansion
Top Tier Retailers
With the recent signing of DPG Distribution, one of the nations' leading distributors to top tier-retailers such as Costco, Sears, Best Buy, and a host of others, UV has the opportunity to select retail outlets that can educate the consumer to the unique benefits the Viratech UV -400, along with the importance of Indoor Air Quality overall. A key factor in this deal was DPG's relationship with funding sources such as Wells Fargo for P.O. financing. The biggest hurdle for smaller Companies working with large retail exposure is financing large orders, so the DPG relationship offers considerable advantages.
Internet and Specialty retailers
UV Flu feels it has a host of opportunities in this segment. This space not only includes large internet retailers such as Groupon and Amazon, it can also include specialty internet sites related to allergies, salons, pets, or travel. Infomercial or home-shopping type sites also offer an incredible area of opportunity.
Another area we plan to spend a considerable amount of resources on is the Sleep Market. "The $25 billion sleep market is almost 4 times bigger than the market for air-purification, and customers have overwhelmingly praised the Viratech for its ability to treat all forms of Indoor Air Pollution, which has been shown in clinical studies to be the key environmental factor in causing sleep problems. Customers feel they sleep better with our device, and the added ability to kill airborne bacteria and other contaminants is another major positive. We expect a significant increase in demand for our products, as we announce major endorsements, well as national and international retail availability through outlets and television," said Mr. Lennon.
Medical Sales
"We are also committed to gaining increased traction on the medical side," said Mr. Lennon. "We are in talks with interested parties in helping us gain access to the reimbursable and non-reimbursable side of the hospital and residential medical device market, and we think with our installed base of products in almost 600 hospitals worldwide, we have the potential to make some major inroads."
"Almost 99,000 people died from hospital-associated infections last year, along with 529,038 surgical site infections in 2010. UV light is now becoming the accepted standard for fighting surface and airborne contaminants. The Viratech UV-400 is the only pure UV based, FDA cleared technology for fighting airborne infection approved for sale in hospitals in the US, China and India. We offer an incredible cost advantage over UV based systems designed to fight surface contamination, which typically can run from $80,000 to $135,000 per unit," said Mr. Lennon.
Our markets for the medical side include emergency room waiting and treatment areas, nurseries, oncology, patient rooms and transplant areas.
Enforcing & Licensing our Patented Technology
The Company is going to pursue finding a top tier law firm to review our patents and related technology for licensing revenue and potential enforcement of our patent portfolio. The company has patents in the US and Worldwide. Our patents have several key factors that make our technology unique and we hope to capitalize on that. We will update shareholders as information becomes available.
International Expansion
The Company is actively seeking additional distributors for its entire product line in the Mideast, Europe and India, along with a host of other countries.
We are convinced that the best way for investors to learn about us as an investment is to try our product. We have found that once an investor uses our technology they understand not only the need but the value proposition. Any shareholders or interested investors interested in buying a Viratech UV-400 unit at a discounted price, can call the Company at 877-FLU-KILL.
Further details regarding the Company's business, acquisitions, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, visit: www.uvflutech.com, and click on the 5 minute video describing the Viratech UV-400.
About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer; manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector ($7 billion in 2011). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: www.uvflutech.com.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.-----------------------------John J. Lennon, President & CEO
Investor Information: Toll-Free: 1-877-358-5545 (FLU-KILL) Web: www.uvflutech.com
Retail or Internet Inquires: Please call our Corporate Office at: 508-362-5455
Looks like some action with news coming out.
News Out Today!
UVFT - Low Float - News out - Long term play
UVFT Heating up...
Volume plus News = :)
UVFT - News out!
UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
CENTERVILLE, Mass., Dec. 4, 2012 /PRNewswire via COMTEX/ -- UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that it has signed a distribution agreement with the Davison Product Group, LLC, aka DPG Distribution, of Heathrow, Florida.
DPG is one of the country's largest distributors of high-end retail consumer electronic products, with a client list of hundreds of the nation's foremost retail chains. DPG sales channels also include state and federal government, military, and online merchants.
"We are thrilled to be working with DPG," said Jack Lennon, President of UV Flu. "DPG is one of the nation's premier retail distributors, offering worldwide service in sales, marketing, distribution and in-store support. We particularly feel akin to their focus in providing the ultimate customer experience through products of impeccable quality, and the latest technology and innovation. DPG clients include catalogue retailers Frontgate and Brookstone and leading retail clients Costco, Amazon, Best Buy, QVC and countless others. In addition to the retail contacts, DPG offers PO funding for its manufacturing partners through Wells Fargo Bank, which will help us ramp up our production capacity in the next quarter," said Mr. Lennon.
Further details regarding the Company's business, acquisitions, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, visit: www.uvflutech.com, and click on the 5 minute video describing the Viratech UV-400.
About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer; manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector ($7 billion in 2011). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: www.uvflutech.com.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.-----------------------------John J. Lennon, President & CEO
Investor Information: Toll-Free: 1-877-358-5545 (FLU-KILL) Web: www.uvflutech.com
SOURCE UV Flu Technologies, Inc.
www.prnewswire.com
Copyright (C) 2012 PR Newswire. All rights reserved
-0-
KEYWORD: Massachusetts
Florida
INDUSTRY KEYWORD: OTC
BIO
IDC
MEQ
MTC
HEA
CSE
CPR
REA
SUBJECT CODE: CON
News out!
UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
CENTERVILLE, Mass., Dec. 4, 2012 /PRNewswire via COMTEX/ -- UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that it has signed a distribution agreement with the Davison Product Group, LLC, aka DPG Distribution, of Heathrow, Florida.
DPG is one of the country's largest distributors of high-end retail consumer electronic products, with a client list of hundreds of the nation's foremost retail chains. DPG sales channels also include state and federal government, military, and online merchants.
"We are thrilled to be working with DPG," said Jack Lennon, President of UV Flu. "DPG is one of the nation's premier retail distributors, offering worldwide service in sales, marketing, distribution and in-store support. We particularly feel akin to their focus in providing the ultimate customer experience through products of impeccable quality, and the latest technology and innovation. DPG clients include catalogue retailers Frontgate and Brookstone and leading retail clients Costco, Amazon, Best Buy, QVC and countless others. In addition to the retail contacts, DPG offers PO funding for its manufacturing partners through Wells Fargo Bank, which will help us ramp up our production capacity in the next quarter," said Mr. Lennon.
Further details regarding the Company's business, acquisitions, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, visit: www.uvflutech.com, and click on the 5 minute video describing the Viratech UV-400.
About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer; manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector ($7 billion in 2011). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: www.uvflutech.com.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.-----------------------------John J. Lennon, President & CEO
Investor Information: Toll-Free: 1-877-358-5545 (FLU-KILL) Web: www.uvflutech.com
SOURCE UV Flu Technologies, Inc.
www.prnewswire.com
Copyright (C) 2012 PR Newswire. All rights reserved
-0-
KEYWORD: Massachusetts
Florida
INDUSTRY KEYWORD: OTC
BIO
IDC
MEQ
MTC
HEA
CSE
CPR
REA
SUBJECT CODE: CON
This will be back at a Penny and a half after the merger.
Watch.
Back to penny land :)
When and if news comes out the insiders will just continue to line their own pockets.
Float! How can the Float be 5 million when 20 million shares have been traded? You think the inside "consultants" with unrestricted shares and their promoters might be selling?
Read the filings people.
Also no update on the filings in 6 Months. Stop sign soon. Just an FYI.
No threat. JMO
Yeah, OK. We'll see when the SEC/Finra investigates this.
Paid Disclosure? Is there any PAID DISCLOSURE on what was paid for this promotion? It's the law so I'd like to know.
News Out!
Ardent Mines Receives Permit to Start Exploration Program at Misty Hills (Serra do Sereno) Project in Carajas, Brazil
Samples at Misty Hills return positive results for gold and silver plus a significant grade for copper
NEW YORK, Aug 23, 2012 (BUSINESS WIRE) -- Ardent Mines Ltd. (OTCQB: ADNT) (the "Company" or "Ardent Mines"), a precious resources exploration, development, and mining company focused on advancing its two gold properties in Brazil, announced that the Brazilian National Department of Minerals Production completed the legal procedures required to transfer exploration rights of the Misty Hills property to Ardent Mines, and that its Brazilian subsidiary, Gold Hills Mining Ltda., received a definitive exploration permit from the Ministry of Mines and Energy allowing the Company to commence its exploration program.
Mr. Luciano Borges, President of Gold Hills Mining Ltda. and President of Ardent Mines Ltd., commented, "Misty Hills is located within one of the premier mining districts in Brazil, well known worldwide for hosting significant iron, copper and gold deposits. New discoveries are still being made in the area and many mines are currently under construction. We look forward to commencing our exploration campaign at Misty Hills and reaching the same level of advances that have been made at our other property, Serra do Ouro ("Gold Hills"), where drilling is starting this week."
Misty Hills is a highly mineralized area of 9,000 Hectares located in the Carajas Mineral Province, State of Para. The property was initially prospected by Anglo American Brasil Ltda. which identified important gold and copper anomalies, forming a trend with a 23 km footprint.
The Misty Hills exploration activities are under the final planning stage, and the Company has three to six years under applicable authorizations to conclude the exploration work.
Mr. Borges, commenting on the results of sample tests completed at Misty Hills, stated, "The potential of the area was confirmed by a chemical analysis obtained from two rock samples collected during our due diligence period. The tests provided positive results for gold and silver, as well as a high copper grade exceeding the detection limits of the standard analytical method used to test the samples."
The rock samples at Misty Hills were completed by Acme Analytical Laboratories Ltd., Vancouver, British Columbia, an IS0 9001:2008 accredited facility.
ABOUT ARDENT MINES
Ardent Mines plans to develop low cost gold mining operations in Brazil, a mining friendly jurisdiction on two primary projects, Gold Hills and Misty Hills. Ardent Mines owns a 100% interest in Gold Hills Mining Ltda., which in turn owns mineral rights on 3,500 hectares, covering a highly-mineralized gold trend containing high grades of gold. Ardent Mines also owns the mineral rights on the Serra do Sereno (Misty Hills) property, located in Carajas, Brazil, one of the better known mining districts in the world. Ardent Mines is headquartered in New York, and has a field office in Brasilia. The Company has 16.3 million shares outstanding, and trades under the ticker symbol ADNT.
For more information on Ardent Mines Ltd., visit its website at www.ardentmines.com.
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. These forward-looking statements are based upon currently available competitive, geological, financial, and economic data and management's views and assumptions regarding future events. Such forward-looking statements are inherently uncertain. Our actual results may vary materially from those expressed in any forward-looking statements as a result of various factors and uncertainties. Ardent Mines cannot provide assurances that any prospective matters described in the press release will be successfully completed or that Ardent Mines will realize the anticipated benefits of any mining activities or transactions. Various risk factors that may affect our business, results of operations and financial condition are detailed from time to time in the Annual Report on Form 10-K and in the Current Reports on Form 8-K and other filings made by Ardent Mines with the U.S. Securities & Exchange Commission. Ardent Mines undertakes no obligation to update information contained in this release.
Neither the OTC nor any Market Regulation Services Provider (as that term is defined in the policies of the OTC and SEC) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Ardent Mines Ltd.
CONTACT:
Ardent Mines Ltd. Luciano Borges, 55.61.30334964 President 855.ARDENTM (273.3686) Email: info@ardentmines.com
Copyright Business Wire 2012
-0-
KEYWORD: United States
Brazil
North America
South America
New York
INDUSTRY KEYWORD: Natural Resources
Mining/Minerals
Other Natural Resources
SUBJECT CODE: Product/Service
Take a look - ADNT
ADNT News out! Check out their chart since January...
Breaking News on ADNT
ADNT - Ardent Mines Receives Permit to Start Exploration Program at Misty Hills (Serra do Sereno) Project in Carajas, Brazil
Samples at Misty Hills return positive results for gold and silver plus a significant grade for copper
NEW YORK, Aug 23, 2012 (BUSINESS WIRE) -- Ardent Mines Ltd. (OTCQB: ADNT) (the "Company" or "Ardent Mines"), a precious resources exploration, development, and mining company focused on advancing its two gold properties in Brazil, announced that the Brazilian National Department of Minerals Production completed the legal procedures required to transfer exploration rights of the Misty Hills property to Ardent Mines, and that its Brazilian subsidiary, Gold Hills Mining Ltda., received a definitive exploration permit from the Ministry of Mines and Energy allowing the Company to commence its exploration program.
Mr. Luciano Borges, President of Gold Hills Mining Ltda. and President of Ardent Mines Ltd., commented, "Misty Hills is located within one of the premier mining districts in Brazil, well known worldwide for hosting significant iron, copper and gold deposits. New discoveries are still being made in the area and many mines are currently under construction. We look forward to commencing our exploration campaign at Misty Hills and reaching the same level of advances that have been made at our other property, Serra do Ouro ("Gold Hills"), where drilling is starting this week."
Misty Hills is a highly mineralized area of 9,000 Hectares located in the Carajas Mineral Province, State of Para. The property was initially prospected by Anglo American Brasil Ltda. which identified important gold and copper anomalies, forming a trend with a 23 km footprint.
The Misty Hills exploration activities are under the final planning stage, and the Company has three to six years under applicable authorizations to conclude the exploration work.
Mr. Borges, commenting on the results of sample tests completed at Misty Hills, stated, "The potential of the area was confirmed by a chemical analysis obtained from two rock samples collected during our due diligence period. The tests provided positive results for gold and silver, as well as a high copper grade exceeding the detection limits of the standard analytical method used to test the samples."
The rock samples at Misty Hills were completed by Acme Analytical Laboratories Ltd., Vancouver, British Columbia, an IS0 9001:2008 accredited facility.
ABOUT ARDENT MINES
Ardent Mines plans to develop low cost gold mining operations in Brazil, a mining friendly jurisdiction on two primary projects, Gold Hills and Misty Hills. Ardent Mines owns a 100% interest in Gold Hills Mining Ltda., which in turn owns mineral rights on 3,500 hectares, covering a highly-mineralized gold trend containing high grades of gold. Ardent Mines also owns the mineral rights on the Serra do Sereno (Misty Hills) property, located in Carajas, Brazil, one of the better known mining districts in the world. Ardent Mines is headquartered in New York, and has a field office in Brasilia. The Company has 16.3 million shares outstanding, and trades under the ticker symbol ADNT.
For more information on Ardent Mines Ltd., visit its website at www.ardentmines.com.
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. These forward-looking statements are based upon currently available competitive, geological, financial, and economic data and management's views and assumptions regarding future events. Such forward-looking statements are inherently uncertain. Our actual results may vary materially from those expressed in any forward-looking statements as a result of various factors and uncertainties. Ardent Mines cannot provide assurances that any prospective matters described in the press release will be successfully completed or that Ardent Mines will realize the anticipated benefits of any mining activities or transactions. Various risk factors that may affect our business, results of operations and financial condition are detailed from time to time in the Annual Report on Form 10-K and in the Current Reports on Form 8-K and other filings made by Ardent Mines with the U.S. Securities & Exchange Commission. Ardent Mines undertakes no obligation to update information contained in this release.
Neither the OTC nor any Market Regulation Services Provider (as that term is defined in the policies of the OTC and SEC) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Ardent Mines Ltd.
CONTACT:
Ardent Mines Ltd. Luciano Borges, 55.61.30334964 President 855.ARDENTM (273.3686) Email: info@ardentmines.com
Copyright Business Wire 2012
-0-
KEYWORD: United States
Brazil
North America
South America
New York
INDUSTRY KEYWORD: Natural Resources
Mining/Minerals
Other Natural Resources
SUBJECT CODE: Product/Service
Check out ADNT - NEWS!
ADNT - Breaking News!
ADNT - News Out!
ADNT...Great chart - No hype.
Look at ADNT!
The chart is great since 2012
ADNT - Chart looks great since January 2012
Check out ADNT's Chart since January...
Nice looking stock.
ADNT - Check out this chart since January 2012
http://www.otcmarkets.com/stock/ADNT/chart
ADNT - Check out this chart since January 2012
http://www.otcmarkets.com/stock/ADNT/chart
NEWS OUT!
Ardent Mines to Initiate Exploratory Drilling at Gold Hills (Serra do Ouro)
NEW YORK, Aug 16, 2012 (BUSINESS WIRE) -- Ardent Mines Ltd. (OTCQB: ADNT) (the "Company" or "Ardent Mines"), a precious resources exploration, development, and mining company focused on advancing its two gold properties in Brazil, announced today that it has contracted DRILRENT Ltd. ("DRILRENT"), a Brazilian-based company with more than 30 years experience, to commence an exploratory drilling campaign at Gold Hills (Serra do Ouro), the Company's flagship property located in Northeast Brazil.
"This is another significant step in the advancement of our Gold Hills project," stated Luciano Borges, geologist and President of Ardent Mines. "Our technical team recently refined the geological and structural mapping of the main gold occurrences identified within the project and as a result identified seven zones with richer mineralization potential. This initial exploratory drilling will focus on those areas."
Mr. Borges continued, "DRILRENT was selected based on their successful experience in the region, their state-of-the-art equipment, flexibility to begin drilling immediately and availability of additional drill rigs if needed. And, importantly, they were cost effective."
The drilling contract, which is expected to be complete by late September, covers 3,300 meters for a total cost of approximately $700,000.
ABOUT ARDENT MINES
Ardent Mines plans to develop low cost gold mining operations in Brazil, a mining friendly jurisdiction on two primary projects, Gold Hills and Misty Hills. Ardent Mines owns a 100% interest in Gold Hills Mining Ltda., which in turn owns mineral rights on 3,500 hectares, covering a highly-mineralized vein containing high grades of gold. Ardent Mines also owns the mineral rights on the Serra do Sereno (Misty Hills) property, located in Carajas, Brazil, one of the better known mining districts in the world. Ardent Mines is headquartered in New York, and has a field office in Brasilia. The Company has 16.3 million shares outstanding, and trades under the ticker symbol ADNT.
For more information on Ardent Mines Ltd., visit its website at www.ardentmines.com.
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. These forward-looking statements are based upon currently available competitive, geological, financial, and economic data and management's views and assumptions regarding future events. Such forward-looking statements are inherently uncertain. Our actual results may vary materially from those expressed in any forward-looking statements as a result of various factors and uncertainties. Ardent Mines cannot provide assurances that any prospective matters described in the press release will be successfully completed or that Ardent Mines will realize the anticipated benefits of any mining activities or transactions. Various risk factors that may affect our business, results of operations and financial condition are detailed from time to time in the Annual Report on Form 10-K and in the Current Reports on Form 8-K and other filings made by Ardent Mines with the U.S. Securities & Exchange Commission. Ardent Mines undertakes no obligation to update information contained in this release.
Neither the OTC nor any Market Regulation Services Provider (as that term is defined in the policies of the OTC and SEC) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Ardent Mines Ltd.
CONTACT:
Ardent Mines Ltd. Luciano Borges, 55-61-30334964 855-ARDENTM (273-3686) President info@ardentmines.com
Copyright Business Wire 2012
-0-
KEYWORD: United States
North America
New York
INDUSTRY KEYWORD: Natural Resources
Mining/Minerals
Other Natural Resources
Environment
SUBJECT CODE: Contract/Agreement
ADNT - Check out this chart since January 2012
http://www.otcmarkets.com/stock/ADNT/chart
ADNT - Check out this chart since January 2012
http://www.otcmarkets.com/stock/ADNT/chart
ADNT - Check out this chart since January 2012
[url][/url][tag]http://www.otcmarkets.com/stock/ADNT/chart
ADNT - Check out this chart since January 2012
[url][/url][tag]http://www.otcmarkets.com/stock/ADNT/chart
Back to a penny now:)
The chart on this stock is GREAT!
Looks like the selling is over perhaps.
Now upwards and onward.
They must run out of shares soon?